'Identifying key players' presentation slideshows

Age Related Macular Degeneration Pipeline Review, H1 2015

220 views • 7 slides

Acute Lymphoblastic Lymphoma Pipeline Overview 2015

139 views • 6 slides

Abdominal Aortic Aneurysms Therapeutic Pipeline Review, H1 2015

204 views • 6 slides

Anaplastic Thyroid Cancer Pipeline Therapeutics Assessment Review H2 2015

This report provides comprehensive information on the therapeutic development for Anaplastic Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anaplastic Thyroid Cancer and special features on late-stage and discontinued projects

233 views • 6 slides

Birch Pollen Allergy Pipeline Therapeutics Assessment Review H2 2015

This report provides comprehensive information on the therapeutic development for Birch Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy and special features on late-stage and discontinued projects

208 views • 6 slides

Leiomyosarcoma Pipeline Therapeutics Development Review H2 2015

This report provides comprehensive information on the therapeutic development for Leiomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Leiomyosarcoma and special features on late-stage and discontinued projects

200 views • 6 slides

Fibrosarcoma Pipeline Therapeutics Assessment Review H2 2015

This report provides comprehensive information on the therapeutic development for Fibrosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibrosarcoma and special features on late-stage and discontinued projects

252 views • 6 slides

Multiple Myeloma (Kahler Disease) Market Forecast & Future Industry Trends 2015

284 views • 5 slides

Type-1 diabetes (Juvenile Diabetes) Market 2015

242 views • 5 slides

Key Factors for Attention Deficit Hyperactivity Disorder (ADHD) Market 2015

231 views • 5 slides